Loading
VP
Vodis Pharmaceuticals Inc. Stock: price and insider trades · Canada
Vodis Pharmaceuticals Inc.: what insiders have been doing
Vodis Pharmaceuticals Inc. is a listed company. Filings by its managers are published through SEDI. Nothing new has been filed by managers of Vodis Pharmaceuticals Inc. in twelve months, the latest record being from 27 November 2020.
Looking back to 2016, when coverage begins, insiders filed 43 purchases and 125 sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
190
Thresholds
n/a
Buy Volume
€45,330
43 ops. · all time
Sell Volume
€1M
125 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 27 November 2020
Declarations190 total
45,000 shares@ CA$0.0606Common SharesTSXSEDI:3632367
Canonical exit: 25 Feb 2021 (T+90)
23,000 shares@ CA$0.05Common SharesTSXSEDI:3596782
Canonical exit: 30 Nov 2020 (T+90)
2,000 shares@ CA$0.05Common SharesTSXSEDI:3595614
Canonical exit: 29 Nov 2020 (T+90)
1,000 shares@ CA$0.05Common SharesTSXSEDI:3594753
Canonical exit: 26 Nov 2020 (T+90)
20,000 shares@ CA$0.05Common SharesTSXSEDI:3594147
Canonical exit: 25 Nov 2020 (T+90)
101,000 shares@ CA$0.06Common SharesTSXSEDI:3592527
20,000 shares@ CA$0.06Common SharesTSXSEDI:3591998
Canonical exit: 19 Nov 2020 (T+90)
30,000 shares@ CA$0.0550.1% of flowCommon SharesTSXSEDI:3591215
Canonical exit: 18 Nov 2020 (T+90)
20,000 shares@ CA$0.050.1% of flowCommon SharesTSXSEDI:3590715
Canonical exit: 17 Nov 2020 (T+90)
15,000 shares@ CA$0.0550.0% of flowCommon SharesTSXSEDI:3590153
Canonical exit: 16 Nov 2020 (T+90)
230,000 shares@ CA$0.050.7% of flowCommon SharesTSXSEDI:3590152
Canonical exit: 16 Nov 2020 (T+90)
5,000 shares@ CA$0.050.0% of flowCommon SharesTSXSEDI:3589322
Canonical exit: 12 Nov 2020 (T+90)
50,000 shares@ CA$0.0550.2% of flowCommon SharesTSXSEDI:3589320
Canonical exit: 12 Nov 2020 (T+90)
13,000 shares@ CA$0.050.0% of flowCommon SharesTSXSEDI:3588471
Canonical exit: 12 Nov 2020 (T+90)
9,000 shares@ CA$0.050.0% of flowCommon SharesTSXSEDI:3588470
Canonical exit: 11 Nov 2020 (T+90)
29,000 shares@ CA$0.050.1% of flowCommon SharesTSXSEDI:3587476
Canonical exit: 9 Nov 2020 (T+90)
8,000 shares@ CA$0.050.0% of flowCommon SharesTSXSEDI:3587666
Canonical exit: 10 Nov 2020 (T+90)
10,000 shares@ CA$0.0550.0% of flowCommon SharesTSXSEDI:3586736
Canonical exit: 5 Nov 2020 (T+90)
1,000 shares@ CA$0.050.0% of flowCommon SharesTSXSEDI:3586737
Canonical exit: 8 Nov 2020 (T+90)
30,000 shares@ CA$0.050.1% of flowCommon SharesTSXSEDI:3585166
Canonical exit: 5 Nov 2020 (T+90)
30,000 shares@ CA$0.050.1% of flowCommon SharesTSXSEDI:3584732
Canonical exit: 4 Nov 2020 (T+90)
33,000 shares@ CA$0.050.1% of flowCommon SharesTSXSEDI:3581264
Canonical exit: 26 Oct 2020 (T+90)
9,000 shares@ CA$0.050.0% of flowCommon SharesTSXSEDI:3580929
Canonical exit: 25 Oct 2020 (T+90)
20,000 shares@ CA$0.0510.1% of flowCommon SharesTSXSEDI:3580348
Canonical exit: 22 Oct 2020 (T+90)
10,000 shares@ CA$0.050.0% of flowCommon SharesTSXSEDI:3579589
Canonical exit: 20 Oct 2020 (T+90)
25 of 190 declarations
About Vodis Pharmaceuticals Inc.
Vodis Pharmaceuticals Inc. is a company focused on developing pharmaceutical products based on cannabis. It is listed on the Toronto Stock Exchange (XTSE).
